sumatriptan

(redirected from Imitrex STATdose)
Also found in: Dictionary.
Related to Imitrex STATdose: Sumatriptan succinate, Alsuma

sumatriptan

 [soo″mah-trip´tan]
a selective serotonin receptor agonist used as the succinate salt in the acute treatment of migraine and cluster headaches; administered orally, subcutaneously, or intranasally.

sumatriptan

/su·ma·trip·tan/ (soo″mah-trip´tan) a selective serotonin receptor agonist used as the succinate salt in the acute treatment of migraine and cluster headaches.

sumatriptan

(so͞o′mə-trĭp′tn)
n.
A triptan drug, C14H21N3O2S, used also in the form of its succinate to treat migraine headache and cluster headache.

sumatriptan

A SEROTONIN antagonist drug that has been found effective in the symptomatic treatment of acute MIGRAINE. A brand name is Imigran.
References in periodicals archive ?
On October 3, 2005, Allergan announced that it entered into a long-term agreement with GSK to develop and promote Allergan's Botox(R) in Japan and China and to co-promote GSK's products Imitrex STATdose System(R) (sumatriptan succinate) and Amerge(R) (naratriptan hydrochloride) in the United States.
On October 3, 2005, Allergan announced that it entered into a long-term agreement with GlaxoSmithKline (GSK) to develop and promote Allergan's Botox(R) (botulinum toxin type A) in Japan and China and to co-promote GSK's products Imitrex STATdose System(R) (sumatriptan succinate) and Amerge(R) (naratriptan hydrochloride) in the United States.
NYSE:AGN) announced today that it has entered into a long-term agreement with GlaxoSmithKline (NYSE:GSK) to develop and promote Allergan's BOTOX(R) (botulinum toxin type A) in Japan and China and to co-promote GSK's products IMITREX STATdose System(R) (sumatriptan succinate) and AMERGE(R) (naratriptan hydrochloride) in the United States.
In addition, Allergan has obtained the right to co-promote GSK's products IMITREX STATdose System(R) and AMERGE(R) in the U.